Skip to content
Novabase Plus

Giving Pluripotent Cells in Utero to Infants with Neural Tube Defect Boosts Quality of Life, Research Shows

A groundbreaking research effort has revealed that delivering regenerative cells to unborn babies diagnosed with spina bifida during corrective surgery can be a "major milestone" in treating birth defects.

Trial Details and Safety

The US-based trial involved six developing infants with the 'open' form of spina bifida. Surgeons applied placenta-derived mesenchymal stem cells directly onto the developing neural column as part of the surgical correction.

Importantly, the regenerative treatment demonstrated a favorable safety profile. Doctors verified that the treatment did not lead to tumors, hinder surgical recovery, or block the correction of related neurological issues.

Positive Developments

Imaging conducted after delivery indicated a successful correction of brainstem displacement in every participant. This brain structure normalization is a key indicator for enhanced physical outcomes.

"If it makes a greater number of infants capable of walking who wouldn't have, it may emerge as the conventional approach," noted the study director. "The results are profoundly encouraging and open the door to lots of potential new treatments."

Future Implications and Hope

Commentators reviewing the findings have suggested that further confirmation of these apparent benefits could signal a "different age" in fetal surgery. The potential to improve neurological damage present before birth is viewed as a revolutionary objective.

Particularly welcome would be better management of continence and digestive health, which are common challenges for people affected by this condition.

The Path Forward

Despite this being a first-in-human effort focused on a handful of cases, its safety demonstration and positive signals offer a robust platform for expanded clinical research. The addition of cellular treatment with current in-utero repair procedures holds considerable promise for improving the prognosis for infants diagnosed prenatally with this neural tube defect.

The writer

Diana Rubio

Lena is a seasoned digital marketer with 8 years of experience helping Dutch brands grow online.

Novabase Plus

Type to search articles.